This Article Full Text Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Fallen, E. L. Articles by Garnett, E. S. Search for Related Content PubMed PubMed Citation Articles by Fallen, E. L. Articles by Garnett, E. S.

(Circulation. 1995;91:1381-1388.)
© 1995 American Heart Association, Inc.

Articles

Redistribution of Myocardial Blood Flow With Topical Nitroglycerin in Patients With Coronary Artery Disease

Ernest L. Fallen, MD, FRCP(C); Claude Nahmias, PhD; Anita Scheffel, BASc; Geoff Coates, MD, FRCP(C); Rob Beanlands, MD, FRCP(C); E. Stephen Garnett, MD, FRCP(C)

From the Departments of Medicine and Nuclear Medicine, McMaster University Medical Centre, McMaster University, Hamilton, Ontario, Canada.

Correspondence to Ernest L. Fallen, MD, McMaster University Medical Centre, Rm 3U4, 1200 Main St W, Hamilton, Ontario, Canada L8N 3Z5.

Background Unlike nonselective coronary vasodilators, nitroglycerin (GTN) is said to exert its primary vasodilatory effect on epicardial conductance vessels. Thus, in experimental models of coronary occlusion GTN appears to preferentially direct blood flow to poststenotic zones of ischemia. This phenomenon has, to date, not been tested in humans. Using positron emission tomography we examined the effect of transdermal GTN on global and regional myocardial perfusion in patients with angiographically proven coronary artery disease.

Methods and Results Myocardial perfusion with [¹³N]ammonia was estimated from dynamic time-activity curves at baseline and 3 hours following application of either a 0.4 mg/h GTN skin patch (n=10) or a placebo patch (n=10) in a double-blind parallel design. From resliced cross-sectional images, regional flow, expressed as [¹³N]ammonia retention, was estimated from 216 myocardial sectors. Ischemia was defined as a significant reduction (>2 SDs from average counts/pixel in maximally perfused zones) in [¹³N]ammonia retention within 10 contiguous myocardial sectors coupled with an increase or no change in counts derived from [¹⁸F]fluorodeoxyglucose. There was no change in global myocardial blood flow as expressed by [¹³N]ammonia retention following either placebo (0.61±0.14 to 0.62±0.12 min^-1) or GTN (0.75±0.22 to 0.74±0.19 min^-1). Conversely, there was a significant increase in the proportion of blood flow to the ischemic zones with GTN (73.9±12.6% to 94.9±17.8%; P<.05). No change in the distribution of blood flow to either ischemic or nonischemic zones was observed with placebo. A slight but insignificant decrease in [¹³N]ammonia retention in nonischemic zones was observed with GTN (1.01±0.31 to 0.93±0.26 min^-1).

Conclusions This study suggests that under resting conditions topical GTN alters myocardial perfusion by preferentially increasing flow to areas of reduced perfusion with little or no change in global myocardial perfusion in patients whose angina is responsive to GTN.

Key Words: radioisotopes • perfusion • nitroglycerin

This article has been cited by other articles:

				R. H.J.A. Slart, A. Agool, D. J. van Veldhuisen, R. A. Dierckx, and J. J. Bax Nitrate Administration Increases Blood Flow in Dysfunctional but Viable Myocardium, Leading to Improved Assessment of Myocardial Viability: A PET Study J. Nucl. Med., August 1, 2006; 47(8): 1307 - 1311. [Abstract] [Full Text] [PDF]

				G. I.W. Galasko and A. Lahiri The non-invasive assessment of hibernating myocardium in ischaemic cardiomyopathy--a myriad of techniques Eur J Heart Fail, June 1, 2003; 5(3): 217 - 227. [Abstract] [Full Text] [PDF]

				E. Tadamura, M. Mamede, S. Kubo, H. Toyoda, M. Yamamuro, H. Iida, N. Tamaki, K. Nishimura, M. Komeda, and J. Konishi The Effect of Nitroglycerin on Myocardial Blood Flow in Various Segments Characterized by Rest-Redistribution Thallium SPECT J. Nucl. Med., May 1, 2003; 44(5): 745 - 751. [Abstract] [Full Text] [PDF]

				R. Sciagra Nitrates and Viability: A Durable Affair J. Nucl. Med., May 1, 2003; 44(5): 752 - 755. [Full Text] [PDF]

				R. S. B. Beanlands, T. D. Ruddy, R. A. deKemp, R. M. Iwanochko, G. Coates, M. Freeman, C. Nahmias, P. Hendry, R. J. Burns, A. Lamy, et al. Positron emission tomography and recovery following revascularization (PARR-1): the importance of scar and the development of a prediction rule for the degree of recovery of left ventricular function J. Am. Coll. Cardiol., November 20, 2002; 40(10): 1735 - 1743. [Abstract] [Full Text] [PDF]

				A. Okamura, H. Rakugi, M. Ohishi, Y. Yanagitani, M. Shimizu, T. Nishii, Y. Taniyama, T. Asai, S. Takiuchi, K. Moriguchi, et al. Additive effects of nicorandil on coronary blood flow during continuous administration of nitroglycerin J. Am. Coll. Cardiol., March 1, 2001; 37(3): 719 - 725. [Abstract] [Full Text] [PDF]

				H. A. Dakik, N. S. Kleiman, J. A. Farmer, Z.-X. He, J. A. Wendt, C. M. Pratt, M. S. Verani, and J. J. Mahmarian Intensive Medical Therapy Versus Coronary Angioplasty for Suppression of Myocardial Ischemia in Survivors of Acute Myocardial Infarction : A Prospective, Randomized Pilot Study Circulation, November 10, 1998; 98(19): 2017 - 2023. [Abstract] [Full Text] [PDF]

				L. Ma, L. Chen, L. Gillam, D. D Waters, and C. Chen Nitroglycerin Enhances the Ability of Dobutamine Stress Echocardiography to Detect Hibernating Myocardium Circulation, December 2, 1997; 96(11): 3992 - 4001. [Abstract] [Full Text]

				Z.-X. He, R. Medrano, J. T. Hays, J. J. Mahmarian, and M. S. Verani Nitroglycerin-Augmented 201Tl Reinjection Enhances Detection of Reversible Myocardial Hypoperfusion : A Randomized, Double-Blind, Parallel, Placebo-Controlled Trial Circulation, April 1, 1997; 95(7): 1799 - 1805. [Abstract] [Full Text]